BIO-Key International Inc BKYI.OQ BKYI.O is expected to show a rise in quarterly revenue when it reports results on August 12 (estimated) for the period ending June 30 2025
The Holmdel New Jersey-based company is expected to report a 49.0% increase in revenue to $1.7 million from $1.14 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for BIO-Key International Inc is for a loss of 15 cents per share.
The one available analyst rating on the shares is "buy".
The average consensus recommendation for the electronic equipment & parts peer group is also "Buy".
Wall Street's median 12-month price target for BIO-Key International Inc is $2.00, about 62% above its last closing price of $0.76
This summary was machine generated August 8 at 13:24 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)